切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2022, Vol. 16 ›› Issue (02) : 146 -151. doi: 10.3877/cma.j.issn.1674-0785.2022.02.007

临床研究

心衰伴肺部感染患者血清CHE、NT-proBNP、PCT水平与心功能的相关性及预后预测价值
包艳春1, 关秀军1, 邱虹1,()   
  1. 1. 430010 武汉,湖北省武汉市第八医院心内科
  • 收稿日期:2021-06-28 出版日期:2022-02-15
  • 通信作者: 邱虹
  • 基金资助:
    湖北省卫生计生委面上项目(WJ2017M197)

Serum CHE, NT-proBNP, and PCT levels in patients with heart failure complicated with pulmonary infections: correlation with cardiac function and prognostic value

Chunyan Bao1, Xiujun Guan1, Hong Qiu1,()   

  1. 1. Department of Cardiology, Wuhan Eighth Hospital, Wu Han 43001, China
  • Received:2021-06-28 Published:2022-02-15
  • Corresponding author: Hong Qiu
引用本文:

包艳春, 关秀军, 邱虹. 心衰伴肺部感染患者血清CHE、NT-proBNP、PCT水平与心功能的相关性及预后预测价值[J/OL]. 中华临床医师杂志(电子版), 2022, 16(02): 146-151.

Chunyan Bao, Xiujun Guan, Hong Qiu. Serum CHE, NT-proBNP, and PCT levels in patients with heart failure complicated with pulmonary infections: correlation with cardiac function and prognostic value[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(02): 146-151.

目的

分析心力衰竭(HF)合并社区获得性肺炎(CAP)患者血清胆碱酯酶(CHE)、N末端B型脑钠肽前体(NT-proBNP)、降钙素原(PCT)水平与心功能的相关性及预后预测价值,为临床诊断和治疗工作提供依据。

方法

选取2019年2月至2020年3月湖北省武汉市第八医院心内科收治的296例HF合并CAP患者作为研究组;选取同期的50例单纯CAP患者作为CAP组;选取50例单纯HF患者作为HF组。对3组患者入院时血清CHE、NT-proBNP、PCT水平及研究组患者的心功能分级、临床特征、28 d死亡率进行比较和分析。对研究组患者28 d死亡率进行随访,并根据患者的预后将其分为死亡组(58例)和存活组(238例)。

结果

随着心功能分级的升高,患者的血清CHE水平逐渐降低,血清NT-proBNP、PCT水平逐渐升高(P<0.05);血清CHE、NT-proBNP、PCT水平与心功能分级均具有相关性(P<0.05)。血清CHE、NT-proBNP、PCT水平预测患者预后的受试者工作特征曲线下面积(AUC)分别为0.734、0.685、0.718(P<0.05),当将三者联合检测时,AUCROC提升至0.907。

结论

HF合并CAP患者血清CHE水平的下降和血清NT-proBNP、PCT水平的上升与其心功能损害具有相关性,并可辅助预测患者的短期预后,当三者联合检测时可显著提升预测效能。

Objective

To analyze the correlation of serum cholinesterase (CHE), N-terminal pro-brain natriuretic peptide (NT-proBNP), and procalcitonin (PCT) levels with cardiac function and their prognostic value in patients with heart failure (HF) complicated with community acquired pneumonia (CAP) to provide a basis for clinical diagnosis and treatment.

Methods

A total of 296 patients with HF and CAP admitted to the Department of Cardiology of Wuhan Eighth Hospital of Hubei Province from February 2019 to March 2020 were selected as a study group; 50 patients with simple CAP in the same period were selected as a CAP group and 50 patients with simple HF as an HF group. The levels of serum CHE, NT-proBNP, and PCT at admission and cardiac function grade, clinical characteristics, and 28-day mortality were compared among the three groups. The 28-day mortality of the study group was followed, and the patients were divided into a death group (58 cases) and a survival group (238 cases) according to the prognosis.

Results

With the increase of cardiac function grade, serum CHE level decreased gradually, while serum NT-proBNP and PCT levels increased gradually (P<0.05). Serum CHE, NT-proBNP, and PCT levels were correlated with cardiac function classification (P<0.05). The areas under receiver operating characteristic curves (AUCs) of serum CHE, NT-proBNP, and PCT levels in predicting the prognosis of patients were 0.734, 0.685, and 0.718, respectively (P<0.05). When the three markers were combined together, the AUC increased to 0.907.

Conclusion

The decrease of serum CHE level and the increases of serum NT-proBNP, PCT levels in HF patients with CAP are correlated with the damage of cardiac function, which can help to predict the short-term prognosis of patients. Combined detection of the markers can significantly improve the prediction efficiency.

表1 3组患者血清CHE、NT-proBNP、PCT水平的比较(
xˉ
±s
表2 不同心功能分级患者血清CHE、NT-proBNP、PCT水平(
xˉ
±s
表3 2组患者的临床特征及血清CHE、NT-proBNP、PCT水平
表4 血清CHE、NT-proBNP、PCT水平预测患者预后的ROC曲线分析
图1 血清CHE、NT-proBNP、PCT水平预测患者预后的ROC曲线注:CHE为胆碱酯酶;NT-proBNP为N末端B型脑钠肽前体;PCT为降钙素原
1
Wang X, Hao G, Chen L, et al. Heart failure and left ventricular dysfunction in older patients with chronic kidney disease: the China hypertension survey (2012-2015) [J]. J Geriatr Cardiol, 2020, 17(10): 597-603.
2
Yao Y, Zhang R, An T, et al. Cost-effectiveness of adding dapagliflozin to standard treatment for heart failure with reduced ejection fraction patients in China [J]. ESC Heart Fail, 2020, 7(6): 3582-3592.
3
李世军. 老年心力衰竭流行病学和病理生理学及预后的研究进展 [J]. 中华老年心脑血管病杂志, 2021, 23(3): 318-320.
4
张绍江, 祁庆, 税小波. 老年心力衰竭患者合并肺部感染及预后影响因素 [J]. 中华医院感染学杂志, 2021, 31(2): 203-207.
5
Ariyaratnam JP, Lau DH, Sanders P, et al. Atrial fibrillation and heart failure: epidemiology, pathophysiology, prognosis, and management [J]. Card Electrophysiol Clin, 2021, 13(1): 47-62.
6
Yao C, Wang L, Shi F, et al. Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with heart failure [J]. Int J Med Sci, 2021, 18(7): 1592-1599.
7
中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会, 等. 中国心力衰竭诊断和治疗指南2018 [J]. 中华心血管病杂志, 2018, 46(10): 760-789.
8
Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America [J]. Am J Respir Crit Care Med, 2019, 200(7): e45-e67.
9
Boyland E, Biochem J. Chemical changes in muscle: Part Ⅱ. Invertebrate muscle. Part Ⅲ. Vertebrate cardiac muscle [J]. 1928, 22(2): 362-380.
10
Flack JM, Calhoun D, Schiffrin EL. The new ACC/AHA hypertension guidelines for the prevention, detection, evaluation, and management of high blood pressure in adults [J]. Am J Hypertens, 2018, 31(2): 133-135.
11
American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019 [J]. Diabetes Care, 2019, 42(Suppl 1): S13-S28.
12
Vogelmeier CF, Criner GJ, Martínez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary [J]. Arch Bronconeumol, 2017, 53(3): 128-149.
13
张雪兰, 陈娟, 万曦, 等. 血清Gal-3、NT-pro-BNP及hs-CRP水平与慢性心力衰竭超声心动图指标的相关性研究 [J]. 现代生物医学进展, 2020, 20(19): 3707-3710.
14
侯修敏, 张银妆, 匡圆圆, 等. 2013-2016年湘雅医院心力衰竭住院患者的病因、诊治特点及预后影响因素 [J]. 临床与病理杂志, 2018, 38(3): 538-546.
15
王建军, 董海山, 温丽荣. 入院时心力衰竭对感染性休克患者预后的影响 [J]. 中国急救医学, 2018, 38(1): 26-30.
16
Stølen TO, Høydal MA, Ahmed MS, et al. Exercise training reveals micro-RNAs associated with improved cardiac function and electrophysiology in rats with heart failure after myocardial infarction [J]. J Mol Cell Cardiol, 2020, 148: 106-119.
17
Zhou XJ, Zhang X, Zhang J, et al. Diagnostic value of growth differentiation factor-15 and beta2-microglobulin in children with congenital heart disease combined with chronic heart failure and its relationship with cardiac function [J]. Eur Rev Med Pharmacol Sci, 2020, 24(15): 8096-8103.
18
葛晓竹, 田巍, 邓晓慧, 等. 血清胆碱酯酶、C反应蛋白在老年肺部感染患者诊断及预后评估中价值 [J]. 临床军医杂志, 2019, 47(12): 1359-1361.
19
Seo M, Yamada T, Tamaki S, et al. Prognostic significance of serum cholinesterase in patients with acute decompensated heart failure: A prospective comparative study with other nutritional indices [J]. Am J Clin Nutr, 2019, 110(2): 330-339.
20
Yasuda S, Fukata M, Yokoyama T, et al. Sick sinus syndrome observed in a patient with cholinesterase deficiency [J]. Intern Med, 2019, 58(6): 809-812.
21
Agunloye OM, Oboh G, Ademiluyi AO, et al. Cardio-protective and antioxidant properties of caffeic acid and chlorogenic acid: mechanistic role of angiotensin converting enzyme, cholinesterase and arginase activities in cyclosporine induced hypertensive rats [J]. Biomed Pharmacother, 2019, 109: 450-458.
22
任慧惠, 赵亮, 李旭军. 血清胆碱酯酶与重症肺部感染患者应激性高血糖及预后的相关性分析 [J]. 解放军医药杂志, 2018, 30(3): 70-72, 76.
23
赵瑞巧, 张晓娟, 王海旭, 等. 血清胆碱酯酶对感染性休克预后的预测价值 [J]. 中华危重病急救医学, 2020, 32(1): 44-49.
24
魏星, 刘文果. 心力衰竭伴感染患者炎性因子、氨基末端B型钠尿肽的水平变化及临床意义 [J]. 河北医药, 2018, 40(16): 2502-2505.
25
McKechnie DG, Papacosta AO, Lennon LT, et al. Inflammatory markers and incident heart failure in older men: the role of NT-proBNP [J]. Biomark Med, 2021, 15(6): 413-425.
26
Velissaris D, Zareifopoulos N, Lagadinou M, et al. Procalcitonin and sepsis in the emergency department: an update [J]. Eur Rev Med Pharmacol Sci, 2021, 25(1): 466-479.
27
司志燕, 宋文奇, 冯晓红, 等. 血清降钙素原对慢性心力衰竭急性发作患者的临床评估价值 [J]. 中国感染控制杂志, 2019, 18(1): 42-46.
[1] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[2] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[3] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[4] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[5] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[6] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[7] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[8] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[9] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[10] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[11] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[12] 曾明芬, 王艳. 急性胰腺炎合并脂肪肝患者CT 与彩色多普勒超声诊断参数与其病情和预后的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 531-535.
[13] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[14] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文


摘要